Part 2 treatment pathway analysis of incident dementia patients in four electronic health record databases in Europe

Aug-18

Database Mental Health Neurology Pharmacoepidemiology

AUTHORS : Glen James, AstraZeneca, Academy House, 136 Hills Road, Cambridge, CB2 8PA, UK – Email: glen-jamesphd@hotmail.com – Cannot find his details for GSK, no longer works there

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 27(S2):212-213

DOI : 10.1002/pds.4629

Part 2 treatment pathway analysis of incident dementia patients in four electronic health record databases in Europe

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement